Factors Associated with Men's Assessment of Prostate Cancer Treatment Choice
Factors Associated with Men's Assessment of Prostate Cancer Treatment Choice
复制标题
DOI：
10.1007/s13187-015-0837-9
复制
发表时间：
2016-06-01
影响因子：
1.6
通讯作者：
LaVeist, Thomas A.
中科院分区：
文献类型：
--
作者：
Ross, Louie E.;Howard, Daniel L.;LaVeist, Thomas A.
本研究的目的是检查北卡罗来纳州的一组非洲裔美国人和白色男性之间的因素，以及他们对前列腺癌治疗选择的评估或认为选择的治疗是最好的。在2007-2008年期间，从北卡罗来纳州癌症登记处招募了一组有前列腺癌诊断史的男性样本（N = 877），并要求他们参加电话访谈，内容涉及有关其初始前列腺癌治疗的几项措施。Logistic回归用于评估人口统计学，心理社会和临床因素，以确定他们是否认为自己选择了最佳治疗方法。受访者大多数是白色（52.7%），已婚（75.9%），并以手术（67.9%）作为其初始治疗。在双变量水平上，与选择最佳治疗的信念相关的因素如下：白色种族/民族、较高的教育水平、最近的治疗日期、有健康保险、接受的治疗类型、副作用带来的较高水平的困扰、对生活质量的更大满意度以及医生对各种治疗方案的讨论。同样，多变量分析显示，在人口统计学（即，种族/民族、教育水平和健康保险覆盖率）以及心理社会和临床变量（即，副作用带来的更大困扰，对生活质量的更大满意度，以及接受的初始治疗）。结果表明，人口统计学，心理社会和临床因素在评估男性前列腺癌的治疗选择中发挥着重要作用。
The objective of this study is to examine factors among a group of African American and White men in North Carolina and their assessment of prostate cancer treatment choice or belief that treatment chosen was best. A sample of men (N = 877) with a history of prostate cancer diagnosis was recruited from the North Carolina Cancer Registry during 2007-2008 and asked to participate in a telephone interview covering several measures about their initial prostate cancer treatment. Logistic regression was used to assess demographic, psychosocial, and clinical factors on whether they felt that they had chosen the best treatment for the disease. Respondents were majority White (52.7 %), married (75.9 %), and had surgery (67.9 %) as their initial treatment. At the bivariate level, factors associated with the belief that the treatment chosen was best were as follows: White race/ethnicity, higher levels of education, a more recent treatment date, having health insurance coverage, type of treatment received, higher levels of bother from side effects, greater contentment with their quality of life, and doctor discussions of the various treatment options. Similarly, the multivariate analysis showed increased odds of belief that the treatment chosen was the best among demographic (i.e., race/ethnicity, level of education, and health insurance coverage) as well as psychosocial and clinical variables (i.e., greater bother from side effects, greater contentment with their quality of life, and initial treatment received). Results suggest that demographic, psychosocial, and clinical factors play an important role for men in assessing their treatment choices for prostate cancer.